New aprepitant suspension for use in children

Emend (aprepitant) is now available as a powder for oral suspension, allowing use of the neurokinin NK1 antagonist in children aged 6 months and over.

Licensed for the prevention of nausea and vomiting associated with highly and moderately emetogenic chemotherapy, the oral suspension can be prescribed for children aged 6 months to 11 years weighing at least 6kg. The recommended dose is based on body weight and should be administered one hour before chemotherapy on days 1, 2 and 3 or in the morning on days 2 and 3 if no chemotherapy is being given.

The oral suspension is supplied as 125mg powder in a sachet to provide a 125mg/5ml oral suspension after reconstitution. Emend capsules containing 80mg or 125mg aprepitant remain available for adults and adolescents.

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

Register or Subscribe to MIMS

GPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.

Register or subscribe

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS Adviser

Especially created for prescribing influencers.

Request free copy

Mobile apps

MIMS: access the full drug database and quick-reference tables on the go

MIMS Diagnosis and Management: concise information on signs and symptoms, investigations and diseases